leisure time -WSS

leisure time

author：comprehensive 2025-08-11 08:00:03 - browse：11

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Aspartame and sugar

leisure time

Wikipedia

WSS

Appeals court upholds limits to abortion pill

Judge sides with young activists in first

What to know about the judge who will handle the Trump case

Neuroscience startup Neumora files for IPO

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Dozens dead from Maui wildfires: What we know about the victims

focus

leisure time

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

2024 GOP presidential candidates spar over abortion in debate

Medicare details structure of new drug price negotiation program

Australia’s approach to dialysis celebrates life

Tori Bowie and the unacceptable rates of Black maternal death

What do new weight loss drugs mean for bariatric surgery?

Anesthesiologist group: stop taking Ozempic before surgery

BMS, looking to build heart drug business, turns to AI for diagnosis

Malaria cases in Florida and Texas: Here’s what you need to know

How Long Island became the ‘eugenics capital of the world’

hotspot

AstraZeneca bets AAV gene therapy will still deliver the goods

Biogen’s boardroom scandal saddles CEO with first crisis

Maui wildfire now ranks as the fifth

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Megan Rapinoe shares emotional post following US Women's World Cup exit

What to know about the judge who will handle the Trump case

leisure time

hotspot

Wikipedia

hotspot